20 Jan 2019 | 11:26 AM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
685.05
-7.60
(-1.09 %)
18 Jan 2019 | 04:01 PM
Change company
  • Open (Rs)
    688.00
  • Prev. close (Rs.)
    692.65
  • High (Rs.)
    690.60
  • Low (Rs.)
    682.00
  • 52W H (Rs.)
    1,031.91
  • 52W L (Rs.)
    637.40
  • Volume
    4320
  • MCap (Rs in Cr.)
    12,602.32
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
37.74
Operating Margin (%)
42.49
Gross Profit Margin (%)
39.46
Net Profit Margin (%)
31.86
Total Debt/Equity
0.06
Dividend payout Ratio (Net Profit)
26.09
Earning Retention Ratio
73.87

News

05 Nov 2018 - 16:43:00-Natco Pharma Monday reported over two-fold increase in consolidated profit after tax at Rs 181...
09 Aug 2018 - 10:43:00-Drug firm Natco Pharma today reported a 93...
02 Jul 2018 - 13:50:00-Natco Pharma today said it has launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for...
11 Jun 2018 - 00:01:00-Natco Pharma Limited has said that it has launched a generic version of Posaconazole Inject...

Announcements

18-Jan-2019
Natco Pharma - Buyback
05-Jan-2019
Natco Pharma - Shareholding for the Period Ended December 31 2018
05-Jan-2019
Natco Pharma - Statement Of Investor Complaints For The Quarter Ended December 2018
21-Dec-2018
Natco Pharma - Buyback
06-Dec-2018
Natco Pharma - Corporate Action-Intimation of Buy back

Religare Research

07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...
04 Jan 2019 | 09:57 AM
The rupee settled at 70.19 to a dollar, its lowest since Dec. 27, against 70.17 at previous close. I...
03 Jan 2019 | 09:56 AM
The rupee settled at 70.17 to a dollar, its lowest since Dec. 27, against 69.45 at previous close. T...
02 Jan 2019 | 09:51 AM
The rupee settled at 69.45 to a dollar, its highest since Aug. 10, against 69.77 at previous close. ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 28.87 -0.93
4,00,000 90.05 139.46 -0.92
4,00,000 90.05 147.86 -0.93
4,00,000 90.05 49.65 -0.92
1,60,000 35.89 76.03 -1.46

Shareholding Pattern

       
Promotors48.42%
Mutual Funds/UTI5.13%
FI/Banks0.96%
Insurance0.96%
FII23.82%
Government0.00%
Others3.93%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
8,063.00(-1.51)
3280
 Sanofi India Ltd.
6,383.80(0.31)
3325
 Pfizer Ltd.
2,658.75(-1.14)
3370
 Dr. Reddy`s Laboratories Ltd.
2,599.50(-0.66)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.-19.90-41.50-93.15
NIFTY(S&P CNX)-1.75603.40-73.50
BSE SENSEX39.532,070.9813.17
BSE 500-64.29784.07-216.97

Corporate Details

Key Personal
D Linga Rao
Director & President (Tech. Affairs)
P S R K Prasad
Director & Exe. VP (Corp. Engg. Services)
Rajeev Nannapaneni
Vice Chairman & CEO
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar